ArticleExpert opinion on pharmacotherapy2023

Intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis.

Francesc Camps et al.PubMed ↗Publisher ↗

No numbers read from the abstract.